文献速递肾癌与肾肿瘤

3-5期慢性肾病患者在肾部分切除术中能否从保留缺血技术获益?

Do patients with Stage 3-5 chronic kidney disease benefit from ischaemia-sparing techniques during partial nephrectomy?
PubMed 文献 · BJU Int · 2019-12-26

本研究纳入462例基线为CKD 3-5期接受机器人辅助肾部分切除术的患者,比较主肾动脉阻断、选择性动脉阻断和零缺血技术对肾功能的影响。多变量线性混合效应模型显示,与主肾动脉阻断相比,选择性动脉阻断和零缺血技术均未显著改善eGFR变化,且在失血量、并发症、住院时间和手术切缘方面也无获益。

要点

  • 在基线CKD 3-5期患者中,选择性动脉阻断和零缺血技术未显著改善eGFR。
  • 选择性动脉阻断与主肾动脉阻断的eGFR变化差异无统计学意义。
  • 零缺血技术与主肾动脉阻断的eGFR变化差异无统计学意义。

核心结论

  • 在基线CKD患者中,机器人辅助肾部分切除术中采用选择性动脉阻断或零缺血技术未显示对eGFR保护的获益。

研究设计与样本

  • 回顾性比较462例基线CKD 3-5期接受机器人辅助肾部分切除术的患者,其中主肾动脉阻断375例(81.2%)、选择性动脉阻断48例(10.4%)、零缺血39例(8.4%)。
  • 采用多变量线性混合效应模型分析随访期间eGFR变化,中位随访12.0个月(IQR 6.7-16.5,范围3.0-24.0个月)。

主要发现

  • 选择性动脉阻断与主肾动脉阻断相比,eGFR随时间变化无显著差异(β=-1.20,95%CI -5.45至3.06,P=0.582)。
  • 零缺血与主肾动脉阻断相比,eGFR随时间变化无显著差异(β=-1.57,95%CI -5.21至2.08,P=0.400)。
  • 总体上仅20例患者(主肾动脉阻断15例、选择性动脉阻断2例、零缺血3例)在末次随访时CKD分期进展。
  • 主肾动脉阻断的平均缺血时间为17分钟,选择性动脉阻断为15分钟。
  • 选择性动脉阻断或零缺血在失血量、围手术期并发症、住院时间或手术切缘方面均无获益。

临床怎么用

  • 对于基线CKD 3-5期患者,选择保留缺血技术(选择性动脉阻断或零缺血)不应期望改善肾功能结局。
  • 在决策时需综合考虑其他临床因素,而非仅依赖保留缺血技术来保护肾功能。

局限性

  • 本研究为回顾性分析,样本量有限,尤其选择性动脉阻断和零缺血组例数较少。
  • 随访时间较短,中位随访仅12.0个月,长期肾功能影响未评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To analyse whether selective arterial clamping (SAC) and off-clamp (OC) techniques during robot-assisted partial nephrectomy (RPN) are associated with a renal functional benefit in patients with Stage 3-5 chronic kidney disease (CKD). PATIENTS AND METHODS: The change in estimated glomerular filtration rate (eGFR) over time was compared between 462 patients with baseline CKD 3-5 that underwent RPN with main arterial clamping (MAC) (n = 375, 81.2%), SAC (n = 48, 10.4%) or OC (n = 39, 8.4%) using a multivariable linear mixed-effects model. All follow-up eGFRs, including baseline and follow-up between 3 and 24 months, were included in the model for analysis. The median follow-up was 12.0 months (interquartile range 6.7-16.5; range 3.0-24.0 months). RESULTS: In the multivariable linear mixed-effects model adjusting for characteristics including tumour size and the R.E.N.A.L. (Radius; Exophytic/Endophytic; Nearness; Anterior/Posterior; Location) Nephrometry Score, the change in eGFR over time was not significantly different between SAC and MAC RPN (β = -1.20, 95% confidence interval [CI] -5.45, 3.06; P = 0.582) and OC and MAC RPN (β = -1.57, 95% CI -5.21, 2.08; P = 0.400). Only 20 (15 MAC, two SAC, three OC) patients overall had progression of their CKD stage at last follow-up. The mean ischaemia time was 17 min for MAC and 15 min for SAC. There was no benefit to SAC or OC in terms of blood loss, perioperative complications, length of stay, or surgical margins. CONCLUSION: SAC and OC techniques during RPN were not associated with benefit in preservation of eGFR in patients with baseline CKD.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Beksac AT, Okhawere KE, Rosen DC, et al. Do patients with Stage 3-5 chronic kidney disease benefit from ischaemia-sparing techniques during partial nephrectomy? BJU Int. 2019. PMID: 31758657. doi:10.1111/bju.14956

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。